Phase 3 study for people with Type 2 Diabetes

Recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 3
Sponsor AstraZeneca
Registry number NCT07664553
Started 8 July 2026 Today 16 October 2026 Estimated completion 23 May 2028

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Research Site Campbelltown NSW Not yet recruiting
Research Site East Toowoomba QLD Recruiting
Research Site Heidelberg Heights VIC Not yet recruiting
Research Site Parkville VIC Not yet recruiting
Research Site St Leonards NSW Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 600

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Diagnosed with T2DM for at least 90 days prior to screening

* Stable treatment with background insulin and other background glucose-lowering medication(s)

* HbA1c value of ≥ 7% to ≤ 10.5%

* Body mass index (BMI) of ≥ 23 kg/m2 at screening

* Stable body weight (self-reported or documented) for 90 days prior to screening

Exclusion Criteria:

* T1DM, secondary forms of diabetes (including congenital forms), or history of ketoacidosis or hyperosmolar coma

* Currently receiving or anticipated to receive, therapeutic intervention for diabetic retinopathy and/or macular edema

* Have had more than one episode of severe hypoglycemia within 180 days prior to screening or has a history of hypoglycemia unawareness or poor recognition of hypoglycemic symptoms

* Clinically significant condition affecting the upper GI tract or chronic use of any medication that affects gastric motility or gastric emptying

* History of acute or chronic pancreatitis.

* Severe congestive heart failure (NYHA IV)

* History/family history of medullary thyroid cancer or multiple endocrine neoplasia type 2

Dates on the record

Started 8 July 2026
Estimated completion 23 May 2028
Registry last updated 4 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 4 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.